Not Signed In -
Guanfacine |
Tenex |
Guanfacine Systematic (IUPAC) name N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide Identifiers CAS number 29110-47-2 ATC code C02AC02 PubChem 3519 DrugBank APRD00075 Chemical data Formula C9H9Cl2N3O Mol. weight 246.093 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status ℞ Prescription only Routes ? Guanfacine is a cen ...
Wikipedia - [full article]
Guanfacine Clinical Trials
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00004376 - Completed
Tourette Syndrome
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
ClinicalTrials.gov Identifier: NCT00469664 - Recruiting
Schizophrenia; Schizoaffective Disorder; Cognitive Impairment
- Guanfacine for Improving Cognitive Symptoms in People With Schizotypal Personality Disorder
ClinicalTrials.gov Identifier: NCT00353379 - Recruiting
Schizotypal Personality Disorder; Personality Disorders
- Guanfacine to Treat Borderline Personality Disorder
ClinicalTrials.gov Identifier: NCT00358969 - Recruiting
Borderline Personality Disorder
- Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)
ClinicalTrials.gov Identifier: NCT00018603 - Completed
Post-Traumatic Stress Disorder
- SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms
ClinicalTrials.gov Identifier: NCT00367835 - Completed
ADHD
- Safety and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
ClinicalTrials.gov Identifier: NCT00152009 - Completed
Attention Deficit Disorder with Hyperactivity
- Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
ClinicalTrials.gov Identifier: NCT00150618 - Completed
Attention Deficit Disorder with Hyperactivity
- Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
ClinicalTrials.gov Identifier: NCT00150592 - Completed
Attention Deficit Disorder with Hyperactivity
- Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 with Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov Identifier: NCT00151996 - Completed
Attention Deficit Disorder with Hyperactivity
- Methylphenidate in Children and Adolescents with Pervasive Developmental Disorders
ClinicalTrials.gov Identifier: NCT00025779 - Completed
Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Pervasive Development Disorders
Resources
- Guanfacine (Drug Digest)
- Tenex (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
